title: Leptin reverses declines in satiation in weight-reduced obese humans.
abstract: BACKGROUND
  Individuals who are weight-reduced or leptin deficient have a lower energy expenditure coupled with higher hunger and disinhibition and/or delayed satiation compared with never-weight-reduced control subjects. Because exogenous leptin inhibits feeding in congenitally leptin-deficient humans, reduced leptin signaling may reduce the expression of feeding inhibition in humans.
  
  
  OBJECTIVE
  The objective was to test the hypothesis that reduced leptin signaling may reduce the expression of feeding inhibition (ie, blunt satiation) in humans by examining the effects of leptin repletion on feeding behavior after weight loss.
  
  
  METHODS
  Ten obese humans (4 men, 6 women) were studied as inpatients while they received a weight-maintaining liquid-formula diet. Satiation was studied by measuring intake and ratings of appetite-related dispositions 3 h after ingestion of 300 kcal of the liquid-formula diet. The subjects were studied at each of 3 time periods: 1) while they maintained their usual weight (Wt(initial)) and then after weight reduction and stabilization at 10% below initial weight and while they received 5 wk of either 2) twice-daily injections of placebo (Wt(-10%placebo)) or 3) "replacement doses" of leptin (Wt(-10%leptin)) in a single-blind crossover design with a 2-wk washout period between treatments. Energy expenditure was also measured at each study period.
  
  
  RESULTS
  Both energy expenditure and visual analog scale ratings that reflect satiation were significantly lower at Wt(-10%placebo) than at Wt(initial) and Wt(-10%leptin).
  
  
  CONCLUSIONS
  The results are consistent with the hypothesis that the absence of leptin signaling after weight loss may blunt the expression of feeding inhibition in humans.
authors.affiliation: St Luke's/Roosevelt Hospital Medical Center, New York, NY, USA.
authors.forename: Harry R
authors.initials: HR
authors.lastname: Kissileff
authors.forename: John C
authors.initials: JC
authors.lastname: Thornton
authors.forename: Migdalia I
authors.initials: MI
authors.lastname: Torres
authors.forename: Katherine
authors.initials: K
authors.lastname: Pavlovich
authors.forename: Laurel S
authors.initials: LS
authors.lastname: Mayer
authors.forename: Vamsi
authors.initials: V
authors.lastname: Kalari
authors.forename: Rudolph L
authors.initials: RL
authors.lastname: Leibel
authors.forename: Michael
authors.initials: M
authors.lastname: Rosenbaum
mesh_terms: D000328:Adult; D001066:Appetite / Q000187:drug effects / Q000502:physiology*; D018592:Cross-Over Studies; D004038:Diet, Reducing; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006801:Humans; D020738:Leptin / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D009765:Obesity / Q000178:diet therapy / Q000378:metabolism / Q000503:physiopathology*; D012527:Satiation / Q000187:drug effects / Q000502:physiology*; D016037:Single-Blind Method; D015431:Weight Loss / Q000502:physiology*
chemical_list: D020738:Leptin